Human umbilical cord mesenchymal stem cell therapy (Hangzhou S-Evans Biosciences)

人脐带间充质干细胞（杭州易文赛生物）

Report date: 2026/02/28 20:00:37

Base Information

Drug NameHuman umbilical cord mesenchymal stem cell therapy (Hangzhou S-Evans Biosciences)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDermatitis, AtopicRespiratory Distress Syndrome, AdultIdiopathic Pulmonary Fibrosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHangzhou S-Evans Biosciences Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHangzhou S-Evans Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicRespiratory Distress Syndrome, AdultIdiopathic Pulmonary Fibrosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A